These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37004660)

  • 1. Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort.
    Sun M; Jiang W
    Discov Oncol; 2023 Apr; 14(1):39. PubMed ID: 37004660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
    Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
    J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friend or foe? The prognostic role of endometriosis in women with clear cell ovarian carcinoma. A UK population-based cohort study.
    Tranoulis A; Buruiana FH; Gupta B; Kwong A; Lakhiani A; Yap J; Balega J; Singh K
    Arch Gynecol Obstet; 2022 May; 305(5):1279-1289. PubMed ID: 34468823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the number of removed lymph nodes according to FIGO stage in ovarian clear cell carcinoma.
    Tamura K; Takei Y; Matsubara S; Takahashi S; Taneichi A; Takahashi Y; Yoshiba T; Koyanagi T; Saga Y; Fujiwara H
    Mol Clin Oncol; 2021 Dec; 15(6):263. PubMed ID: 34777799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual Tumor Diameter Predicts Progression After Primary Debulking Surgery of Ovarian Clear Cell Carcinoma (OCCC): Clinicopathologic Study of Stage II-IV OCCC Patients from a Single Institution.
    Shi Y; Dai M; Zhang Y; Qi Y; Li Z; Cai H
    Cancer Manag Res; 2021; 13():2215-2222. PubMed ID: 33692636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
    Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
    Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
    Oliver KE; Brady WE; Birrer M; Gershenson DM; Fleming G; Copeland LJ; Tewari K; Argenta PA; Mannel RS; Secord AA; Stephan JM; Mutch DG; Stehman FB; Muggia FM; Rose PG; Armstrong DK; Bookman MA; Burger RA; Farley JH
    Gynecol Oncol; 2017 Nov; 147(2):243-249. PubMed ID: 28807367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre.
    El Tawab S; Nistor S; Roux R; Manek S; Gaitskell K; Ahmed AA; Kehoe S; Soleymani Majd H
    Transl Cancer Res; 2024 Sep; 13(9):5037-5049. PubMed ID: 39430857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
    Wang Q; Wang L; L Y; Ding X; Liu A
    J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinical characteristics and prognosis between clear cell carcinomas and high-grade serous ovarian carcinomas.
    Dong S; Yu F; Liu Y; Yu X; Sun X; Wang W; Wang Y
    Ginekol Pol; 2023; 94(10):792-798. PubMed ID: 36477777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
    Zhu C; Zhu J; Qian L; Liu H; Shen Z; Wu D; Zhao W; Xiao W; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):322. PubMed ID: 33766002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the number of cycles of platinum-based chemotherapy for early stage ovarian clear cell carcinoma on survival: a retrospective study.
    Gao Y
    BMC Womens Health; 2023 May; 23(1):262. PubMed ID: 37189098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.
    Kim HS; Kim MA; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
    Ann Surg Oncol; 2015 Aug; 22(8):2738-45. PubMed ID: 25680339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymph nodes ratio in patients with stage III ovarian clear cell carcinoma: A retrospective study of patients in Southwest China.
    Nie D; Mao X; Li Z
    J Cancer; 2019; 10(19):4689-4694. PubMed ID: 31528234
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
    Aman M; Ohishi Y; Imamura H; Shinozaki T; Yasutake N; Kato K; Oda Y
    Hum Pathol; 2017 Jun; 64():156-163. PubMed ID: 28438620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma.
    Kawabata A; Yanaihara N; Nagata C; Saito M; Noguchi D; Takenaka M; Iida Y; Takano H; Yamada K; Iwamoto M; Kiyokawa T; Okamoto A
    Gynecol Oncol; 2017 Sep; 146(3):609-614. PubMed ID: 28673661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
    Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K
    Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.